Cancer Research Annual Meeting 2010  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 6143-6148, December 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davis, H. M.
Right arrow Articles by Klug, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davis, H. M.
Right arrow Articles by Klug, T. L.

Characterization of the CA 125 Antigen Associated with Human Epithelial Ovarian Carcinomas

H. M. Davis, V. R. Zurawski, Jr., R. C. Bast, Jr. and T. L. Klug1

Centocor, Malvern, Pennsylvania 19355 [H. M. D., V. R. Z., T. L. K.], and Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710 [R. C. B.]

The murine monoclonal antibody OC125 reacts with an antigenic determinant (CA 125) found on a high-molecular-weight glycoprotein complex present in the serum of greater than 80% of women with epithelial ovarian cancer. The antigen expressing CA 125 (CA 125 antigen) isolated from the sera of ovarian carcinoma patients was shown by gel electrophoresis, molecular size exclusion chromatography, and buoyant density ultracentrifugation to have similar immunological and physical characteristics to antigen isolated from an ovarian cancer cell line (OVCA 433) and human milk. A composite sodium dodecyl sulfate:2.5% polyacrylamide:1.0% agarose gel resolved the CA 125 activity from the three sources of antigen into disperse bands of similar electrophoretic mobilities with apparent masses of 200,000 to 1 million daltons. The buoyant densities of the CA 125 antigen complexes from human serum, OVCA 433 cells, and human milk were in the range of 1.36 to 1.46 g/ml. Isolation of CA 125 antigen of higher purity from OVCA 433 supernatant was achieved by a series of steps including OC125 immunoaffinity chromatography. Subsequent resolution of this purified CA 125 antigen complex by sodium dodecyl sulfate:polyacrylamide gel electrophoresis gave rise to a band at approximately 200,000 daltons. Treatment of the CA 125 antigen from OVCA 433 cells with 10 mM periodic acid resulted in no loss of activity. Reduction and alkylation in 6 M guanidine-HCI or treatment at 100°C for 20 min resulted in complete loss of activity. Exoglycosidase treatments did not result in loss of activity, whereas protease digestion eradicated all activity. These data strongly suggest that the CA 125 antigenic determinant is composed of, at least in part, conformationally dependent peptide.

1 To whom requests for reprints should be addressed.

Received 5/27/86. Revised 9/ 4/86. Accepted 9/ 5/86.




This article has been cited by other articles:


Home page
Hum ReprodHome page
M. M. Jankovic and B. S. Tapuskovic
Molecular forms and microheterogeneity of the oligosaccharide chains of pregnancy-associated CA125 antigen
Hum. Reprod., September 1, 2005; 20(9): 2632 - 2638.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Kui Wong, R. L. Easton, M. Panico, M. Sutton-Smith, J. C. Morrison, F. A. Lattanzio, H. R. Morris, G. F. Clark, A. Dell, and M. S. Patankar
Characterization of the Oligosaccharides Associated with the Human Ovarian Tumor Marker CA125
J. Biol. Chem., August 1, 2003; 278(31): 28619 - 28634.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Seelenmeyer, S. Wegehingel, J. Lechner, and W. Nickel
The cancer antigen CA125 represents a novel counter receptor for galectin-1
J. Cell Sci., April 1, 2003; 116(7): 1305 - 1318.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Auersperg, J. Pan, B. D. Grove, T. Peterson, J. Fisher, S. Maines-Bandiera, A. Somasiri, and C. D. Roskelley
E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium
PNAS, May 25, 1999; 96(11): 6249 - 6254.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Bergeron, S. Champetier, Hélèn. LaRue, and Y. Fradet
MAUB Is a New Mucin Antigen Associated with Bladder Cancer
J. Biol. Chem., March 22, 1996; 271(12): 6933 - 6940.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
I. Konishi, J. L. Fendrick, T. H. Parmley, J. G. Quirk JR, and T. J. O'Brien
Epidermal Growth Factor Enhances Secretion of the Ovarian Tumor-Associated Cancer Antigen CAI25 From the Human Amnion WISH Cell Line
Reproductive Sciences, January 1, 1994; 1(1): 89 - 96.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
B. W. T. Yin and K. O. Lloyd
Molecular Cloning of the CA125 Ovarian Cancer Antigen. IDENTIFICATION AS A NEW MUCIN, MUC16
J. Biol. Chem., July 13, 2001; 276(29): 27371 - 27375.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.